到 2027 年北美胰岛素笔市场 - 按产品类型（一次性和可重复使用）进行区域分析和预测；应用（1 型糖尿病和 2 型糖尿病）；分销渠道（医院药房、零售药房和电子商务）和地理位置
No. of Pages: 114 | Report Code: TIPRE00006290 | Category: Life Sciences
No. of Pages: 114 | Report Code: TIPRE00006290 | Category: Life Sciences
预计 2019 年至 2027 年该市场将以 8.7% 的复合年增长率增长。老年人口增长和糖尿病发病率上升等因素推动了市场的增长。然而，由于该地区药物输送替代品的可用性以及与胰岛素笔相关的限制，市场可能会受到影响。
糖尿病是一种危及生命的慢性疾病，没有专门的治疗方法。它主要是由于人体无法产生或有效利用胰岛素激素引起的。这种能力阻碍了身体充分调节血糖水平。糖尿病有两种类型，即 I 型糖尿病（也称为乏味糖尿病）和 II 型糖尿病（也称为糖尿病）。全球范围内，糖尿病的发病率和患病率正在稳步上升。在高收入国家，高达 91% 的成年人患有 2 型糖尿病。
根据国际糖尿病联盟 (IDF) 的数据，大约有 4.25 亿人患有 2 型糖尿病。 2017 年，全球糖尿病患者预计将达到 6.29 亿。 2015年，约9.4%的美国人口患有糖尿病，其中包括3020万18岁及以上的成年人。此外，根据美国疾病控制与预防中心的报告，18至44岁人群中有4%患有糖尿病，45至64岁人群中有17%患有糖尿病，65岁以上人群中有25.2%患有糖尿病。下表列出了全球各个北美国家的糖尿病患者人数。
由于糖尿病患者数量的增长，预计美国将引领北美地区的市场。该地区糖尿病的患病率和老年人口的增加。然而，该国落后于其他发达国家，这可能会限制市场的增长。因此，考虑到上述因素，在预测期内，该国市场的增长可能会在北美地区贡献最大份额。
Strategic insights for North America Insulin Pens involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 1,880.7 Million |
| Market Size by 2027 | US$ 3,907.9 Million |
| Global CAGR (2019 - 2027) | 8.7% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By 产品类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Insulin Pens refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies
The North America Insulin Pens Market is valued at US$ 1,880.7 Million in 2018, it is projected to reach US$ 3,907.9 Million by 2027.
As per our report North America Insulin Pens Market, the market size is valued at US$ 1,880.7 Million in 2018, projecting it to reach US$ 3,907.9 Million by 2027. This translates to a CAGR of approximately 8.7% during the forecast period.
The North America Insulin Pens Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Insulin Pens Market report:
The North America Insulin Pens Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Insulin Pens Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Insulin Pens Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Insulin Pens Market
